SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-025672
Filing Date
2023-02-27
Accepted
2023-02-27 08:22:51
Documents
2
Period of Report
2023-02-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm231898-1_pre14a.htm PRE 14A 399855
2 GRAPHIC lg_rubiustherapeut-4c.jpg GRAPHIC 84840
  Complete submission text file 0001104659-23-025672.txt   508799
Mailing Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38586 | Film No.: 23670148
SIC: 2836 Biological Products, (No Diagnostic Substances)